Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
Ochiai
T
T
Department of Surgery, Chiba University School of Medicine, Japan.
Ishibashi
M
M
Fukao
K
K
Takahashi
K
K
Endo
T
T
Yokoyama
I
I
Uchida
K
K
Ohshima
S
S
Takahara
S
S
Morozumi
K
K
D000681:Amylases / Q000097:blood; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000453:epidemiology; D007668:Kidney / Q000473:pathology; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D011188:Potassium / Q000097:blood; D011239:Prednisolone / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use* / Q000633:toxicity*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D014280:Triglycerides; D014527:Uric Acid; D016572:Cyclosporine; D002784:Cholesterol; D011239:Prednisolone; D000681:Amylases; D011188:Potassium; D016559:Tacrolimus